Area of research
Organic Chemistry · Inorganic Chemistry
Research interest
Research interests include Medicine, Internal medicine, Chemistry, Rituximab, Retrospective cohort study, and Oncology.
591 | NOVEL CHEMOTHERAPY‐FREE INITIAL TREATMENT OF RITUXIMAB PLUS PEGYLATED INTERFERON Α‐2B IN UNTREATED ADVANCED INDOLENT B‐CELL LYMPHOMA: 4‐YEAR FOLLOW‐UP STUDY
Phase I/IIa clinical study of 4th generation BTK inhibitor HBW-3220 capsules in patients with B-cell malignancies.
Real-world, multicenter study of brentuximab vedotin-based regimens in Chinese patients with relapsed/refractory Hodgkin lymphoma
Copper-Catalyzed Asymmetric Remote C(sp<sup>3</sup>)–H Alkylation of <i>N</i>-Fluorocarboxamides with Glycine Derivatives and Peptides
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B‐Cell Lymphoma: A Real‐World, Multi‐Center, Retrospective Cohort Study
Maintenance Therapy of Golidocitinib, a JAK1 Selective Inhibitor, in Patients with Peripheral T Cell Lymphomas after First-Line Systemic Therapy: Updates of the Phase 2 Study (JACKPOT26)
Visible-Light-Driven <i>C,N</i>-Selective Heteroarylation of <i>N</i>-Fluoroalkyl Hydroxylamine Reagents with Quinoxalin-2(1<i>H</i>)-ones
Combination of Mitoxantrone Hydrochloride Liposome with Cyclophosphamide, Vincristine and Prednisone (CMOP) in Treatment-Naïve Patients with Peripheral T-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial